Pulmonary Arterial Hypertension: Many Years' Experience and Modern Approach to a Malignant Disease in a Pulmonary Hypertension Centre

被引:0
作者
Karyofillis, Panagiotis [1 ]
Manginas, Athanasios [1 ]
Thomopoulou, Sofia [1 ]
Balanos, Dimitrios [1 ]
Spargias, Konstantinos [1 ]
Cokkinos, Dennis V. [1 ]
机构
[1] Onassis Cardiac Surg Ctr, Dept Cardiol 1, Athens 17674, Greece
关键词
Right ventricle; pulmonary vascular resistance; pulmonary heart diseases; BRAIN NATRIURETIC PEPTIDE; CALCIUM-CHANNEL BLOCKERS; PROGNOSTIC FACTORS; 1ST-LINE BOSENTAN; FOLLOW-UP; SURVIVAL; INFUSION; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The aim of this study was to record the results from a modern diagnostic and therapeutic approach to patients with pulmonary arterial hypertension. Methods: We studied the clinical characteristics and the treatment of 69 patients (50 women, 72.5%), aged 44 +/- 17 years, who were diagnosed with pulmonary hypertension (World Health Organisation categories 1, IV and V). The patients' outcomes were recorded over 14 years' operation of our Pulmonary Hypertension Unit. Results: Twenty-seven patients (39.1%) suffered from idiopathic pulmonary hypertension, 12 (17.4%) from thromboembolic obstructive disease, 14 (20.3%) from congenital heart diseases, 11 (15.9%) from connective tissue diseases, 3 (4.3%) from portal hypertension, 2 (2.9%) from sarcoidosis, and 1 (1.4%) from pulmonary veno-occlusive disease. Six patients (8.7%) were in New York Heart Association (NYHA) functional class I, 28 (40.6%) were in class II, 30 (43.5%) were in class III, and 5 (7.2%) were in class IV. Thirty-four patients completed a 6-minute walk test and covered a mean distance of 352 +/- 137 m. N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were measured in 18 patients, with a mean value of 1665 1935 pg/ml. A vasoreactivity test in 41 patients had a positive response in 10 (24.4%). Twenty-six patients (37.7%) were treated with combination therapy, whereas 16 (23.2%) either did not comply with or were not given specific medication. The mortality over a mean follow-up period of 5 +/- 4 years was 26%, significantly lower than that reported before the introduction of new drugs. An advanced NYHA class was an independent predictor of mortality (p=0.004), while elevated NT-proBNP levels were also associated with poor survival (p=0.013). Conclusions: Pulmonary arterial hypertension is a severe disease that leads to right heart failure and death. Despite the latest advances, vigilance and continuous investigation are needed in order to achieve a prompt diagnosis and the most suitable treatment.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 34 条
[1]  
Adamopoulos Stamatis, 2007, Hellenic J Cardiol, V48, P123
[2]   Plaque composition in plexogenic and thromboembolic pulmonary hypertension:: the critical role of thrombotic material in pultaceous core formation [J].
Arbustini, E ;
Morbini, P ;
D'Armini, AM ;
Repetto, A ;
Minzioni, G ;
Piovella, F ;
Viganò, M ;
Tavazzi, L .
HEART, 2002, 88 (02) :177-182
[3]   Diagnosis and differential assessment of pulmonary arterial hypertension [J].
Barst, RJ ;
McGoon, M ;
Torbicki, A ;
Sitbon, O ;
Krowka, MJ ;
Olschewski, H ;
Gaine, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :40S-47S
[4]   SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].
BARST, RJ ;
RUBIN, LJ ;
MCGOON, MD ;
CALDWELL, EJ ;
LONG, WA ;
LEVY, PS .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415
[5]   SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].
DALONZO, GE ;
BARST, RJ ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KERNIS, JT ;
LEVY, PS ;
PIETRA, GG ;
REID, LM ;
REEVES, JT ;
RICH, S ;
VREIM, CE ;
WILLIAMS, GW ;
WU, M .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349
[6]   Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension [J].
Fijalkowska, Anna ;
Kurzyna, Marcin ;
Torbicki, Adam ;
Szewczyk, Grzegorz ;
Florczyk, Michal ;
Pruszczyk, Piotr ;
Szturmowicz, Monika .
CHEST, 2006, 129 (05) :1313-1321
[7]  
FROST AE, 2007, AM J RESP CRIT CAR S, V175, pA1001
[8]  
Gibbs JSR, 2002, CIRCULATION, V106, P575
[9]  
Grapsa Ioulia, 2007, Hellenic J Cardiol, V48, P152
[10]  
Gruenig E, 2007, EUR HEART J, V28, P140